Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Crown Energy delays repayment of convertible loan and the interest of the convertible loan

The board of directors of Crown Energy AB (publ) (“Crown Energy” or the “Company”) elected on April 27 to postpone the repayment of the outstanding convertible loan KV1 2013/2016 including interest owed. As communicated on April 4, the Company has entered into an agreement for a private placement that the shareholders will resolve upon at the Annual General Meeting on 4 May. The share issue is expected to be completed following the shareholder approval, approval of a prospectus and some other external conditions to be met. The board of directors sees therefore that adequate capital needed for

UPM's support of the "Local waters" school project enables the project to expand nationwide

(UPM, Helsinki, 28 April 2016 at 10:30 EET) - UPM supports a school project called "Local waters". Originally launched in schools in the city of Rauma, the project will expand to other UPM mill locations in Finland in 2016. The project aims to improve grammar and encourage secondary school students to become more interested in natural sciences-particularly natural science related to water-by exploring the natural waters in the vicinity of the schools. In addition to UPM, the Finnish Environment Institute (SYKE), Raumanmeri Rotary Club and the organisation puhdasvesi.fi are also involved in

Nomination of Hans von Celsing as new chairman of Peptonic Medical

Stockholm 28th April 2016. - Peptonic Medical AB (publ) (”the Company” or ”Peptonic”) – a company developing pharmaceuticals based on oxytocin  - today announces that the Nomination Committee will propose to the Annual General Meeting on May 19th, that Mr Hans von Celsing be elected Chairman of the Board of Peptonic Medical.Mr Ron Long, the present Chairman (since 2009), has announced that he is not standing for re-election. The Nomination Committee also proposes re-election of the board members Prof. Kerstin Uvnäs Moberg, Mrs Nadia Whittley and Prof. Emeritus Andris Kreichbergs.

Quartely report for TagMaster AB January-March 2016

Press release, Sweden, Stockholm, April 28 2016 A robust quarter with extensive development work First quarter · Net sales increased during the first quarter by 28,1% to 24,6 MSEK (19,2) · Result before depreciation (EBITDA) was 2,0 MSEK (2,6), corresponding to a margin of  8,2% (13,74) · Net result after tax was 0,9 MSEK (2,0) · Result per share was 0,01 (0,02) · Cash flow from the business for the period was -0,2 MSEK (3,4) · CitySync Ltd makes a small operating profit for the quarter  After end of period · TagMaster announced April 27 that its intention

Vattenfall’s first quarter 2016: Stable earnings - increased production and lower costs

Vattenfall’s first quarter earnings improved as a result of increased production and lower costs. Underlying operating profit amounted to SEK 8,136 million, an increase of approximately 5 percent compared with the quarter a year ago. However, the negative price trend put continued pressure on operations.First quarter in summary: ·Net sales of SEK 45,929 million (45,377) ·Underlying operating profit of SEK 8,136 million (7,736) ·Operating profit of SEK 10,011 million (8,386) ·Profit after tax of SEK 6,602 million (4,987) ·Electricity generation of 48.7 TWh (

Munksjö proves biodegradability of silicone coated paper release liner

PRESS RELEASE, 28 April 2016, at 09.00 a.m. CESTMunksjö proves biodegradability of silicone coated paper release liner Munksjö, a world-leading manufacturer of advanced papers products, and a leading suppliers of release papers for the Pressure Sensitive Adhesive (PSA) industry, has commissioned a third party laboratory analysis whose results reveal that the typical carrier of PSA labels - silicone coated glassine paper - meets biodegradability requirements of EN 14046:2003 standard. Paper is made from fully renewable natural resources, is recyclable and biodegradable in a short time.

Digital insurance agency partner with Open GI to offer online marketing services

Speedie Consultants Limited have partnered with Open GI, the market leader in Personal and Commercial Lines insurance systems, to offer brokers and insurance partners’ access to specialist online marketing services .The new collaboration aims to provide additional support to Open GI  partners by helping them to generate more income from their online marketing activities as well as driving extra revenue from existing customer bases. Jason Hulott, Business Development Director from Speedie Consultants says: “Working with Open GI

Kværner ASA: Reminder - Invitation to presentation of 1st quarter results 2016

28 April 2016 - Kværner ASA will publish its 1st quarter results 2016 at the Oslo Stock Exchange on Tuesday 3 May 2016 at 07:00 CET. The results presentation will be held at Kvaerner's offices at Fornebuporten, Oksenøyveien 10 at 09:00 CET the same morning. We invite investors, analysts and the media to Kvaerner's results presentation: Date: Tuesday 3 May 2016Time: 09:00 CETLocation: Fornebuporten, Oksenøyveien 10, 1366 LysakerLanguage: English To attend the presentation, please register by emailing ir@kvaerner.com.The presentation will be broadcast live on www.kvaerner.com

JPX taps Cinnober for Risk Monitoring

Next step in the Japanese Exchange’s Next Generation Clearing System ProjectJPX, one of the world’s largest financial marketplaces, has chosen Cinnober for risk monitoring across the entire Japanese market of equities, bonds, futures, options, CDS and IRS. This follows an announcement earlier this year where JPX selected Cinnober for the clearing of the exchange’s listed derivatives market. The new risk monitoring solution, customized and partially based on the risk module in the TRADExpress RealTime Clearing platform, will provide JPX with unique cross-asset risk monitoring and

NeuroVive’s R&D Team to Present Research Progress at Mitochondrial Medicine Conference

NeuroVive Pharmaceutical AB (publ), the pioneers in mitochondrial medicine, will present important research findings together with researchers at Lund University in three scientific poster presentations at the conference entitled “Mitochondrial Medicine: Developing New Treatments for Mitochondrial Disease” being held 4-6 May 2016 in Cambridge, United Kingdom.The three scientific contributions submitted by the NeuroVive and Lund University research team have been accepted for poster presentation at the upcoming mitochondrial conference where global mitochondrial experts will be gathered. The

Strong first quarter performance in DNB Sweden

Pre-tax operating profits for DNB Sweden in the first quarter of 2016 were SEK 351 million, compared with SEK 247 million in the first quarter of 2015. Profits before impairment losses were SEK 362 million, up from SEK 347 million in the same period of 2015. Operating expenses totalled SEK 346 million in the first quarter of 2016, compared with SEK 353 million in 2015. The cost/income ratio was 48.8 per cent, down from 50.5 per cent in the same period of 2015.Performance was better than last year, including lower loan losses. DNB Finans continued to generate healthy profits and made a

Swedish fuel cell company PowerCell Sweden cooperates with Swiss Hydrogen SA to market best in class fuel cell systems

The Nordic leading fuel cell company PowerCell Sweden AB (publ)  has signed a Memorandum of Understanding with Swiss Hydrogen SA , a Switzerland based company that develops hydrogen fuel cell systems for mobile and stationary applications. The two companies will cooperate to market and sell high performance fuel cell systems based on PowerCell's stacks.The Nordic leading fuel cell company PowerCell Sweden AB will start a cooperation with Swiss Hydrogen SA, a Swiss leading company that conceives, designs, assembles and integrates tailor-

Mitsubishi Heavy Industries Ltd. will not exercise the option to change the ownership ratio of MHI Vestas Offshore Wind A/S

Vestas has been notified that Mitsubishi Heavy Industries Ltd. (MHI) will not exercise the option to change the ownership ratio of MHI Vestas Offshore Wind A/S ref. company announcement No. 41/2013 of 27 September 2013 . Equity ownership ratios in MHI Vestas Offshore Wind A/S will consequently remain at 50 percent for each of MHI and Vestas. “We believe that unchanged ownership shares is the best way to support the further development of the joint venture while showing the strong partnership and equal

Interim report January – March 2016

First quarter 2016 · Net asset value per share at the end of the quarter was SEK 86.24, compared to SEK 87.40 at year-end 2015, which represents an decrease of 1.3 per cent. · Bure’s net asset value at the end of the quarter was SEK 5,979M, compared to SEK 6,060M at yearend 2015. · Total return on the Bure share was 1.1 per cent, compared to the SIX Return Index which fell by 3.4 per cent. · Consolidated profit/loss after tax was SEK -75M (1,142). Earnings per share amounted to SEK -1.09 (16.11). Subsequent events · Net asset value per share at 27 April 2016 was SEK 85.

NOTICE OF ORDINARY GENERAL MEETING IN Q-FREE ASA

Trondheim, 28 April 2016:   (This notice is a translation of the Norwegian notice of the Extraordinary General meeting. If any deviation between the two versions, the Norwegian version shall prevail.)Notice is hereby given that an ordinary General meeting in Q-Free ASA will be held on Thursday 26 May 2016 at 16.00 hrs at the Hotel Continental, Stortingsgata 24/26, Oslo.  The notice and papers, together with the notice of attendance and proxy form, are sent to all shareholders whom address is known, registered in the Norwegian Security Depository (VPS) as of 26 April 2016.  In

AddLife’s rights issue fully subscribed

AddLife AB’s (publ) (“AddLife’s”) rights issue with preferential rights for the Company’s shareholders has been fully subscribed. The subscription period for the rights issue ended 25 April, 2016. The final count shows that 199,360 shares of class A and 4,667,229 shares of class B, corresponding to approximately 98.8 percent of the offered shares, were subscribed for with subscription rights. The remaining 2,993 shares of class A and 53,836 shares of class B that were not subscribed for with subscription rights have been allocated to those who have applied for subscription of shares

Diamyd Medical’s CEO purchases shares in the Company

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that CEO Ulf Hannelius has purchased 20,000 Series B shares in Diamyd Medical.“Diamyd Medical is in an exciting phase and it is both an obvious move and gratifying for me to also become a shareholder in the company,” says Ulf Hannelius, CEO of Diamyd Medical. About Diamyd MedicalDiamyd Medical is dedicated to finding a cure for autoimmune diabetes through pharmaceutical development and investments in stem cell and medical technology. Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based

Communiqué from GHP’s Annual General Meeting 2016

The Annual General Meeting of GHP Specialty Care AB (publ) held on 27 April 2016 adopted the following resolutions:· A dividend of SEK 0.15 per share will be paid for the financial year 2015. · Re-election of the members of the Board Carsten Browall, Bo Wahlström, Mikael Olsson, Johan Wachtmeister and Christer Johansson, and election of the new member of the Board Elisabeth Hansson, in accordance with the proposal of the election committee. Carsten Browall was elected as Chairman of the Board. A fee of SEK 400,000 was approved for the Chairman of the Board and SEK 200,000 for each of

MEDIVIR AB – INTERIM REPORT, JANUARY – MARCH 2016

Financial summary for the first quarter · Net turnover totalled SEK 75.0 million (215.9 m), of which SEK 18.1 million (128.6 m) comprised royalties for simeprevir. · Revenues from Medivir’s own pharmaceutical sales totalled SEK 56.2 million (86.8 m), of which SEK 1.8 million (34.2 m) derived from sales of OLYSIO® and SEK 54.5 million (52.6 m) from sales of other pharmaceuticals. · The profit after tax was SEK -40.5 million (66.7 m). · Basic and diluted earnings per share totalled SEK -1.50 (2.29) and SEK -1.49 (2.27), respectively. · The cash flow from operating activities

Interim Report Pricer AB January – March 2016

Highest quarterly order intake and strengthened operating result First quarter 2016 · Net sales of SEK 155.4 M (142.9), an increase of 9 percent compared to last year · Operating profit of SEK 2.2 M (0.9) and profit for the period of SEK 1.1 M (1.3) · Cash flow from operating activities decreased to SEK 20.8 M (42.0) · Order intake of SEK 304 M (269), an increase of 13 percent compared to last year · The backlog[1] is approximately SEK 206 M (226), whereof the majority is expected to be invoiced in the second and third quarter of 2016 Amounts in SEK M unless otherwise

Ericsson resolves on an acquisition offer for C shares for LTV 2016

In accordance with the resolution by the Annual General Meeting 2016, Ericsson (NASDAQ:ERIC) expands its treasury stock in order to provide shares for the Long-Term Variable Compensation Program (LTV) 2016 for employees in Ericsson. The Board of Directors of Ericsson has resolved, by virtue of an authorization given by the Annual General Meeting on April 13, 2016, to direct an acquisition offer to all holders of C shares to acquire these shares. Acquisition shall be made during the period May 5 - May 20, 2016. Payment for acquired shares shall be made in cash with SEK 5 per share. The

AQ Italy acquires Magnetica

On April 27 AQ Italy Srl. acquired 100 % of the shares of Magnetica Srl. The payment to the current owner is € 100. AQ Italy Srl.is recapitalizing Magnetica Srl. with € 500,000 as part of the transaction. The takeover takes place on May 3. Magnetica Srl. designs and manufactures electromagnetic components and power supplies to customers with special requirements. The company has a turnover of approximately EUR 2 million and employs 19 people in Italy and 17 in its production subsidiary in Serbia. "Magnetica has excellent design competence in power supplies and small inductive

Exercise of employee share options in Atea ASA ("the Company")

1. Employees in the Atea Group have exercised 673,639 options. Following the share option exercise the Board of Directors, pursuant to authorisation granted by the Company's Annual General Meeting, has decided to sell 466,969 of the Company's holding of treasury shares and to provide a cash settlement for the remaining 206,670 options exercised. After this transaction the Company holds 7,844 treasury shares. 2. Options exercised by primary insiders 27 April 2016:Attila Fransen has exercised 10,000 options in the Company, corresponding to 10,000 shares at the strike price of NOK 37.50.

Citycon to (re)develop Lippulaiva into a completely new, modern shopping centre

CITYCON OYJ Press release 28 April 2016 at 9.15 amCitycon has made a decision to invest in the Lippulaiva shopping centre development project, located in Espoonlahti, in the Helsinki area. The plan is to demolish the current shopping centre and build a completely new, modern and urban shopping centre that will be double the size of the current centre. The new Lippulaiva’s gross leasable area will be around 42,000 square metres. Citycon’s total investment in the project is around EUR 160–180 million.“We estimate that the project will start this autumn once the contracts required for

There are no items matching the current filter
There are no more items matching the current filter
Back to top